Table 3.
Parameter | Intervention | Control | Intervention-control (Δ) | Statistical significance of intervention versus control at baseline | |||
---|---|---|---|---|---|---|---|
n | Mean ± SD | n | Mean ± SD | Mean difference | z values | p values | |
Weight (kg) | 156 | 81.67 ± 10.72 | 111 | 80.89 ± 12.24 | 0.77 | 0.536 | 0.592 |
BMI (kg/m2) | 156 | 28.21 ± 2.89 | 111 | 28.20 ± 3.59 | 0.02 | 0.039 | 0.969 |
Waist circumference (cm) | 155 | 98.90 ± 8.58 | 111 | 98.89 ± 9.81 | 0.25 | 0.218 | 0.827 |
Hip circumference(cm) | 155 | 103.70 ± 5.72 | 111 | 103.84 ± 7.83 | −0.14 | 0.161 | 0.872 |
Waist-hip ratio | 155 | 0.95 ± 0.06 | 111 | 0.96 ± 0.06 | −0.01 | 0.798 | 0.425 |
Skinfolds (mm) | |||||||
Biceps | 155 | 8.69 ± 4.02 | 108 | 9.26 ± 3.86 | −0.56 | 1.148 | 0.251 |
Triceps | 155 | 16.64 ± 5.69 | 108 | 16.33 ± 5.66 | 0.32 | 0.443 | 0.658 |
Subscapular | 155 | 22.83 ± 6.15 | 108 | 22.88 ± 6.08 | −0.05 | 0.067 | 0.947 |
Suprailiac | 155 | 18.11 ± 6.34 | 108 | 18.80 ± 6.76 | −0.69 | 0.831 | 0.406 |
Sum of peripheral skinfolds | 155 | 25.3 ± 10.13 | 108 | 25.6 ± 9.72 | −0.25 | 0.201 | 0.841 |
Sum of central skinfolds | 155 | 40.9 ± 12.27 | 108 | 41.7 ± 12.93 | −0.80 | 0.504 | 0.614 |
Sum of 4 skinfolds (∑4SF) | 155 | 66.28 ± 18.74 | 108 | 67.27 ± 18.84 | −0.99 | 0.419 | 0.675 |
Systolic blood pressure (mmHg) | 154 | 122.04 ± 13.04 | 100 | 124.67 ± 13.40 | −2.63 | 1.547 | 0.122 |
Diastolic blood pressure (mmHg) | 154 | 82.61 ± 8.95 | 100 | 83.87 ± 9.86 | −1.25 | 1.025 | 0.305 |
Fasting blood glucose (mg/dl) | 148 | 96.52 ± 12.29 | 102 | 98.03 ± 10.41 | −1.51 | −0.998 | 0.318 |
Total cholesterol (mg/dl) | 148 | 187.74 ± 36.00 | 102 | 181.63 ± 36.72 | 6.10 | 1.302 | 0.193 |
High-density lipoprotein cholesterol (mg/dl) | 148 | 40.90 ± 9.51 | 102 | 40.10 ± 8.32 | 0.80 | 0.700 | 0.484 |
Low-density lipoprotein cholesterol (mg/dl) | 148 | 118.00 ± 26.98 | 102 | 117.57 ± 32.38 | 0.43 | 0.111 | 0.912 |
Serum triglycerides (mg/dl) | 148 | 145.74 ± 80.4 | 102 | 137.31 ± 62.48 | 8.43 | 0.931 | 0.352 |